Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.

Related Articles
Recently@Retina Newsletter June 2024 Retina Foundation’s Visionary Luncheon Celebrates Life‑Changing Advancements for Innovative Research and Vision Treatment Retina Foundation of the Southwest New Home in Dallas Eight New Volunteers Join Board of Directors Retina Foundation Completes $3.7M Capital Campaign